![](/regulatory-science-and-affairs/kursusbilleder/Jesper-Kihl-hvid-550x300.jpg?resize=tileslayout)
Danish Health and Medicines Authority
This course is designed to give you the necessary basic background to understand and incorporate drug regulatory affairs in the drug development process.
Knowing how to focus the development process in regards to regulatory affairs and co-operate with the regulatory affairs professionals can be vital for the success of a medicinal product and the survival of a pharmaceutical company.
All aspects within the pharmaceutical development process of medicinal products are subject to various degree of regulation. The pharmaceutical law frame, guidelines, Health Authorities' attitudes and requirements have a significant influence on the drug development process and its success rate.
This course is designed to give you the necessary basic background to understand and incorporate drug regulatory affairs in the drug development process.
Course content
The contents will cover the role and responsibility for the drug regulatory affairs professionals – how they are involved in the development process, how to co-operate with this function, the pharmaceutical law frame in EU, US and outside EU/US, the application and approval procedures, regulatory strategic issue, how to build up an application for a marketing authorization, variations, incentives, pharmacovigilance, and how to approach the issues of Quality, Safety and Efficacy from a regulatory point of view.
The faculty of the course includes a series of experts both from regulatory affairs departments in industry and from the regulatory authorities. In this way the students will receive detailed information from people with hands-on experience in regulatory affairs in their daily work.
The course participants include people from different companies and institutions and with a variety of professional roles. This facilitates the lively discussions during the lectures and even during the breaks.
Course dates
Spring 2026 - dates tba.
The course is available every second year.
Examination
Please find the exam dates in the exam plan.
You can find further information about the course and the exam in the course curriculum.
See an overview of all courses on Master of Industrial Drug Development.
Upon completion of the course you will have an extensive overview and understanding of the drug regulatory affairs in drug development and be able to:
You must meet the following criteria to be admitted to this course:
Find detailed information in the admission criteria on Master of Industrial Drug Development.
Priority is given to enrolled students
This course is offered as a compulsory course in the Master of Industrial Drug Development programme. Priority is given to students already enrolled. Once the enrolled students have been admitted to the course, the remaining seats are distributed on a first-come, first-served basis.
EU/EEA citizens:
12,050 DKK
Non-EU/EEA citizens:
13,825 DKK
The fee includes lunch/coffee.
University of Copenhagen
Department of Pharmacy/
Department of Drug Design and Pharmacology
Universitetsparken 2
2100 Copenhagen
Denmark
Annette Villumsen
Study Administration Officer
Tel.: +45 35 33 60 66